CVS pulls Zantac over cancer fears

Credit: Rumble
Published on October 1, 2019 - Duration: 00:41s

CVS pulls Zantac over cancer fears

CVS said over the weekend it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of possible carcinogen amounts N-nitrosodimethylamine (NDMA) were found in some of the products by the U.S. Food and Drug Administration.

Gavino Garay reports.


You are here

Recent related videos from verified sources

CVS stops selling Zantac, other heartburn medication over cancer fears 02:10
Credit: WPTV News | West Palm Beach - Published on September 30, 2019 

CVS Pulls Heartburn Drug Off Shelves Over Cancer Concerns 00:25
Credit: CBS 3 Philly - Published on September 30, 2019 

You might like